In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Alkermes licenses Alza's oral drug delivery technologies

Executive Summary

Alkermes has acquired exclusive worldwide rights to Alza's RingCap and Dose Sipping oral drug delivery technologies. Alza retains the option to exclusively market any potential products incorporating the technologies in certain therapeutic areas.
Deal Industry
  • Biotechnology
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
Deal Status
  • Final
Deal Type
  • Alliance
    • Manufacturing or Supply
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register